Affera is a medical technology company dedicated to delivering unrivaled innovative solutions to address the rapidly growing cardiac arrhythmia market.
Newton, MA
Joined January 2020
- Tweets61
- Following172
- Followers1.2K
- Likes23
Pinned Tweet
Medtronic receives CE mark approval for the Affera™ Mapping and Ablation System! Find the latest on Affera technologies and clinical programs by following us at @MDT_EPAblation and @medtroniceu #EPeeps #afferaCEmark #affera
Affera™ mapping and ablation system, which includes the Sphere-9™ all-in-one mapping and therapeutic radiofrequency (RF) and pulsed field (PF) ablation catheter, receives CE Mark approval! bit.ly/3YQHAD8
Affera retweeted
Thrilled the first Affera System case took place at Medical Center Hamburg-Eppendorf. Congrats to @AndreasMetzner7 & team. This is the first of sites to come in the next few weeks. Excited to make a difference for patients with this novel innovation #MedtronicEmployee #EPeeps
Thrilled to share that we are the first center worldwide who performed ablation procedures with the Medtronic Affera Mapping and Ablation system! Congratulations to our great team and Medtronic, great achievement!
#Affera #PFA #innovationinhealthcare #electrophysiology #EPeeps
Affera retweeted
Just published! The Affera™ Mapping and Ablation System 12-month outcomes that led to CE Mark were just published in @JACCJournals. Read it now: bit.ly/3oC4F03
Keep up with Affera technologies and clinical programs via Medtronic Channels: @MDT_Cardiac and @MDT_StructHeart starting today!
Affera retweeted
Thoughts after first cases w Affera: 1) having all in one mapping/ablating globe is super efficient (mapped an LAA AT and two SVC ATs on first case- first burn terminations on all three) 2) mapping definition and annotation algorithm is on the money as evidenced above
Affera retweeted
I am fortunate to be a site prinicipal investigator for AFFERA's disruptive pulse-field/radiofrequency atrial fibrillation ablation clinical trial. The cardiac electrophysiology community across the world is looking forward to this trial. I had our cent…lnkd.in/e36Sdvyc
Thank you Drs @EladAnter, Taigen et al. @ClevelandClinic, @natale_md , Burkhardt et al. @tcainstitute and @MoussaMansour10 et al. @harvardmed for a busy and exciting week for @AfferaEP SPHERE PersAF trial!
This is an exciting day for the Affera, Inc. team. Looking forward to partnering with @Medtronic to improve therapies for cardiac arrhythmia patients worldwide.
prnewswire.com/news-releases…
First patient treated in US IDE SPHERE PerAF at @MountSinaiNYC by Drs. @VivekReddyMD @jskoruth @billwhangep and others. Affera also announces $75M series C with Bain Capital Life Sciences.
prnewswire.com/news-releases…
Affera retweeted
*New Research Article* - Pulsed-Field Ablation in Ventricular Myocardium Using a Focal Catheter @eladanter #AHAJournals #Epeeps doi.org/10.1161/CIRCEP.121.0…
Pulse-field ablation in the ventricle: In contrast to biophysics of RFA, lesion repetition of PFA has incremental effect on lesion dimensions, likely via a mechanism of permeability preconditioning. Congrats to @yavin_h ahajournals.org/doi/abs/10.1… @CirculationEP @ClevelandClinic
Affera retweeted
Dose dependent reversible electroporation - effect on AV node conduction. Follow up from last years data on egm amplitude - transient AV block after the pulse that reverses in <1-2 minutes – at Boston, MA
Affera, Inc. Announces Successful First-In-Human Use Of SpherePVI Circumferential Pulmonary Vein Isolation Device ... prn.to/3zGJ3jj
Affera ready to redefine another catheter ablation category. Thank you Drs. Aidietis and Račkauskas at Vilnius University Hospital for hosting us and @EladAnter and @VivekReddyMD for joining us to perform successful FIH procedures last week. Stay tuned…
Affera retweeted
Another PerAF case with Affera PFA: PVI+PWI+MAL: 1st to last lesion <30min with total procedure time <1Hr including mapping and 20min waiting period (no reconnections). We may soon be ready to re-evaluate ablation strategies to treat different types of AF w/ rapid and durable Tx.
Affera retweeted
Persistent AF case with Affera: PVI+Mitral Line+PWI+CTI with transpired therapy time of 30 min. Multiple cases, durable lines, consistent results. High-Res mapping and PFA/RFA from the same lattice catheter at a switch of a button. Exciting times to be in EP and Cleveland Clinic
Affera retweeted
Excellent result with RF/PF ablation using the lattice tip catheter at LBCT #AFSymposium2021
